Related Experiment Video
Updated: Jun 19, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
[Progress in regulation of activity and stability of ubiquitin protein ligase MDM2]
1Department of Biological Sciences and Technology, Tsinghua University, Beijing 100084, China. nnjj2002@163.com
Abstract:
The ubiquitin protein ligase (E3) MDM2 (Murine double minute 2) possesses oncogenic activities. Overexpression of this protein enhances degradation and inactivation of the tumor suppressor p53. At least 7% of all human tumors exhibit inappropriate amplification of mdm2, whereas p53 gene remains in its wild-type configuration. This indicates that MDM2 may function in the p53-independent manner to promote tumorigenesis. Considering the critical role of MDM2, this review summarizes the current mechanisms and progress on MDM2 regulation in levels of gene control, mRNA transcription, post-translational modification, and interaction proteins.
Insights
Murine double minute 2 (MDM2) is an oncogenic protein that promotes tumor growth. This review details MDM2 regulation, highlighting its role in cancer, even independently of the p53 tumor suppressor.
Area of Science:
- Oncogenesis and Cancer Biology
- Molecular Biology and Biochemistry
Background:
- The ubiquitin protein ligase (E3), Murine double minute 2 (MDM2), exhibits oncogenic properties.
- MDM2 overexpression leads to the degradation and inactivation of the tumor suppressor p53.
- MDM2 amplification occurs in at least 7% of human tumors with wild-type p53, suggesting p53-independent oncogenic functions.
Purpose of the Study:
- To review the regulatory mechanisms of MDM2.
- To summarize current progress in understanding MDM2's role in tumorigenesis.
- To explore MDM2's functions beyond its interaction with p53.
Main Methods:
- Literature review of studies on MDM2 regulation.
- Analysis of MDM2's role at different control levels: gene, mRNA, post-translational modification, and protein interactions.
Main Results:
- MDM2 regulates tumorigenesis through multiple mechanisms.
- MDM2's oncogenic activity can be independent of the p53 pathway.
- Comprehensive understanding of MDM2 regulation is crucial for cancer therapy.
Conclusions:
- MDM2 is a critical oncogene with complex regulatory networks.
- Further research into MDM2 regulation, including p53-independent pathways, is essential for developing targeted cancer treatments.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

